ELAVL1 and breast carcinoma: Through binding to Hu antigen R (HUR), an exosomal lncRNA Linc00969 was evidenced to promote the mRNA stability and protein expression of HER2, thereby inducing trastuzumab resistance in HER2-positive breast cancer [387].